It’s about time
Because knowing earlier about cancer recurrence matters to you.
Information for Patients and Caregivers
After a cancer diagnosis, many questions can arise. The results of an MRD test can help provide answers—guiding your doctor in determining the best course of treatment, assessing whether a treatment is working effectively, and detecting any remaining trace amounts of cancer in your body after treatment.
Pathlight, SAGA’s multi-cancer, blood based MRD test, generates a personalized assay, or “ molecular fingerprint”, that can be used to detect the presence or absence of circulating tumor DNA (ctDNA) in blood through routine blood draws.
Pathlight’s unique design and technology creates unparalleled opportunities for detecting recurrence earlier, when treatment is most likely to be successful.
